• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Proteome Res . Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches

tetano

Editor, Senior Moderator
J Proteome Res


. 2020 Oct 29.
doi: 10.1021/acs.jproteome.0c00779. Online ahead of print.
Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches


Antonio Franc?s-Monerris[SUP] 1 2 [/SUP], C?cilia Hognon[SUP] 1 [/SUP], Tom Miclot[SUP] 1 3 [/SUP], Cristina Garc?a-Iriepa[SUP] 4 5 [/SUP], Isabel Iriepa[SUP] 5 6 [/SUP], Alessio Terenzi[SUP] 3 [/SUP], St?phanie Grandemange[SUP] 7 [/SUP], Giampaolo Barone[SUP] 3 [/SUP], Marco Marazzi[SUP] 4 5 [/SUP], Antonio Monari[SUP] 1 [/SUP]



Affiliations

Abstract

The emergence in late 2019 of the coronavirus SARS-CoV-2 has resulted in the breakthrough of the COVID-19 pandemic that is presently affecting a growing number of countries. The development of the pandemic has also prompted an unprecedented effort of the scientific community to understand the molecular bases of the virus infection and to propose rational drug design strategies able to alleviate the serious COVID-19 morbidity. In this context, a strong synergy between the structural biophysics and molecular modeling and simulation communities has emerged, resolving at the atomistic level the crucial protein apparatus of the virus and revealing the dynamic aspects of key viral processes. In this Review, we focus on how in silico studies have contributed to the understanding of the SARS-CoV-2 infection mechanism and the proposal of novel and original agents to inhibit the viral key functioning. This Review deals with the SARS-CoV-2 spike protein, including the mode of action that this structural protein uses to entry human cells, as well as with nonstructural viral proteins, focusing the attention on the most studied proteases and also proposing alternative mechanisms involving some of its domains, such as the SARS unique domain. We demonstrate that molecular modeling and simulation represent an effective approach to gather information on key biological processes and thus guide rational molecular design strategies.

Keywords: COVID-19; SARS unique domain; SARS-CoV-2; coronavirus; docking; drug design; free-energy methods; membrane fusion; molecular dynamics; molecular modeling; proteases; spike protein; structural biophysics.
 
Back
Top Bottom